Ceribell (CBLL) Change in Acquisitions & Divestments (2025 - 2026)
Ceribell posted quarterly Change in Acquisitions & Divestments of $50.0 million for Q1 2026, up 2.67% on a QoQ basis from $48.7 million in Q4 2025.
Ceribell (CBLL) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $50.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $50.0 million; the trailing twelve-month figure through Mar 2026 stood at $144.2 million (changed N/A YoY), and the FY2025 full-year result was $94.2 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $50.0 million, up from $48.7 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $50.0 million in Q1 2026 and bottomed at $6.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ceribell | 666.26 Mn | 525.07 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.00 Mn |
| Mar 31, 2026 | 50.00 Mn |
| Dec 31, 2025 | 48.70 Mn |
| Dec 31, 2025 | 48.70 Mn |
| Sep 30, 2025 | 39.50 Mn |
| Sep 30, 2025 | 39.50 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.00 Mn |